HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Schnaubelt Selected Research

Michael Schnaubelt Research Topics

Disease

12Neoplasms (Cancer)
10/2022 - 01/2018
4Breast Neoplasms (Breast Cancer)
01/2020 - 12/2017
3Adenocarcinoma
10/2022 - 01/2022
2Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 06/2020
2Chromosomal Instability (Chromosome Stability)
01/2020 - 01/2020
1renal Oncocytoma
04/2024
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Pathologic Processes
01/2022
1Carcinoma (Carcinomatosis)
12/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Glioma (Gliomas)
01/2021
1Disease Progression
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Urologic Diseases (Urinary Tract Disease)
01/2019

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2018
6ProteomeIBA
12/2021 - 01/2018
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2020
3GlycopeptidesIBA
12/2021 - 01/2019
3Phenobarbital (Luminal)FDA Link
01/2020 - 12/2017
2Biomarkers (Surrogate Marker)IBA
04/2024 - 12/2021
2EnzymesIBA
12/2020 - 10/2020
2Peptides (Polypeptides)IBA
06/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2020
1NectinsIBA
01/2022
1N-acetyltalosaminuronic acid (NAT)IBA
12/2021
1Messenger RNA (mRNA)IBA
07/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1trametinibIBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1TOR Serine-Threonine KinasesIBA
01/2021
1Polysaccharides (Glycans)IBA
12/2020
1Histones (Histone)IBA
01/2020
1PhosphopeptidesIBA
01/2019

Therapy/Procedure

3Therapeutics
01/2022 - 12/2020
2Precision Medicine
12/2020 - 01/2020
1Lasers (Laser)
10/2022